Benzinga | Aug 28, 2020 10:20AM EDT

'Regulus Therapeutics has been awarded a $300,000 National Institutes of Health contract for research and development of antiviral drugs to cure chronic hepatitis B virus infection.' - TradeHawk

https://twitter.com/TradeHawk/status/1299350593224417281